← Who reports today · Health Care
HSIC · Q2 2026
Archived report (Q2 2026). Latest deep dive →
The quarter in brief
Revenue grew 6.7% y/y to $3.46B, operating margin 4.9% vs 4.7%, net income $94M (+9.3% y/y).
Net income attributable to Henry Schein, Inc.
$94M
up 9.3% y/y
Net sales
$3,458M
up 6.7% y/y
Operating income
$171M
up 13.2% y/y
Gross profit
$1,101M
up 8.4% y/y
All figures in $M.
| Line item | Amount and change |
|---|---|
| Net sales | $3,458 · +6.7% |
| Cost of sales | $2,357 · +6.0% |
| Gross profit | $1,101 · +8.4% · 31.8% margin |
| Selling, general and administrative | $831 · +6.8% |
| Depreciation and amortization | $70 · +9.4% |
| Restructuring and related costs | $29 · +26.1% |
| Operating income | $171 · +13.2% · 4.9% margin |
| Other income (expense): Interest income | $8 · −11.1% |
| Interest expense | $43 · +13.2% |
| Other, net | $1 · vs −$1 |
| Income before taxes, equity in earnings of affiliates and noncontrolling interests | $137 · +13.2% |
| Income taxes | $34 · +9.7% · 24.8% effective rate |
| Equity in earnings (loss) of affiliates, net of tax | $1 · vs $4 |
| Less: Net income attributable to noncontrolling interests | $8 · +0.0% |
| Net income attributable to Henry Schein, Inc. | $94 · +9.3% · $0.82/sh · 2.7% margin |
Verdict: revenue grew 6.7% y/y to $3.46B, operating margin 4.9% vs 4.7%, net income $94M (+9.3% y/y).
Source and notation
Source: Henry Schein press release, 8-K EX-99.1 of 08/04/2026 (SEC EDGAR). Every figure was matched against the income statement in the release and checked against SEC XBRL.
Open as an image: HSIC, Q2 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0
Cite / embed this chart
Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).
Chart: “HSIC Q2 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/hsic/q2-2026. Licensed under CC BY 4.0.
<figure> <a href="https://whoreportstoday.com/t/hsic/q2-2026"><img src="https://whoreportstoday.com/t/hsic/q2-2026/sankey.png" alt="HSIC Q2 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a> <figcaption>Source: <a href="https://whoreportstoday.com/t/hsic/q2-2026">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption> </figure>
https://whoreportstoday.com/t/hsic/q2-2026/sankey.png
<a href="https://whoreportstoday.com/t/hsic/q2-2026">HSIC Q2 2026 earnings chart (Who Reports Today)</a>
This is an archived report: the image at this link won’t change. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.
- Gross margin was 31.8% vs 31.4% a year earlier.
- Operating income was $171M, a 4.9% margin vs 4.7% a year earlier.
- The effective tax rate was 24.8% vs 25.6% a year earlier.
- Diluted EPS was $0.82 vs $0.70 a year earlier.
What distorts the picture in this report and what to watch beyond the headlines.
HSIC — a distributor of health care products and services to dental and medical practices, labs and other care sites that also makes specialty dental products and practice software.
It makes money in three segments: Global Distribution and Value-Added Services (84.5% of 2025 net sales), Global Specialty Products (dental implants, endodontics, orthodontics) and Global Technology. · Source: annual report (Form 10-K, SEC)
More reports: HUM · Q2 2026 · IDXX · Q3 2026 · ILMN · Q3 2026 · INCY · Q2 2026 · IQV · Q3 2026 · ISRG · Q3 2026 · JNJ · Q3 2026 · LH · Q3 2026 · LLY · Q3 2026 · MCK · Q1 FY2027 · all reports